Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients

NCT01368419 is registered in ClinicalTrials.gov with Jiangsu Simcere Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01368419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01368419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients
Lead sponsor
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2011
Completion date
May 31, 2013
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer